Gilead Sciences
GILD
#117
Rank
NZ$306.02 B
Marketcap
NZ$246.80
Share price
-1.55%
Change (1 day)
27.50%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$39.46 Billion

According to Gilead Sciences's latest financial reports the company has NZ$39.46 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$39.05 B14.44%
2024-12-31$NZ$34.12 B-5.13%
2023-12-31$NZ$35.97 B7.69%
2022-12-31$NZ$33.40 B8.32%
2021-12-31$NZ$30.83 B22.12%
2020-12-31$NZ$25.25 B-24.91%
2019-12-31$NZ$33.63 B4.76%
2018-12-31$NZ$32.10 B11.21%
2017-12-31$NZ$28.86 B3.27%
2016-12-31$NZ$27.95 B0.1%
2015-12-31$NZ$27.92 B38.32%
2014-12-31$NZ$20.18 B41.26%
2013-12-31$NZ$14.29 B23.2%
2012-12-31$NZ$11.60 B31.85%
2011-12-31$NZ$8.79 B10.89%
2010-12-31$NZ$7.93 B-11.4%
2009-12-31$NZ$8.95 B16.39%
2008-12-31$NZ$7.69 B63.72%
2007-12-31$NZ$4.70 B77.19%
2006-12-31$NZ$2.65 B-40.12%
2005-12-31$NZ$4.42 B68.95%
2004-12-31$NZ$2.62 B69.93%
2003-12-31$NZ$1.54 B41.33%
2002-12-31$NZ$1.09 B0.2%
2001-12-31$NZ$1.08 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$136.72 B 246.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$152.24 B 285.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$11.14 Billion-128.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$52.54 B 33.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.47 B-60.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$31.41 B-20.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$4.50 B-88.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$32.60 B-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$77.35 B 96.03%๐Ÿ‡บ๐Ÿ‡ธ USA